If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
49
Followers on Owler
Amaranth Medical
develops biodegradable stents to treat peripheral vascular disease...
Read more
Overview
Competitors
Funding
News & Insights
Amaranth Medical
develops biodegradable stents to treat peripheral vascular disease...
Read more
President & CEO
Kamal Ramzipoor
CEO Approval Rating
78/100
Weigh In
2005
Mountain View
California
San Francisco Bay Area
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://amaranthmedical.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$27.5M
News
Latest News
Sep 24, 2018
GlobalNewswire
Press Release: Amaranth Medical : Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT
May 23, 2018
PharmiWeb
Amaranth Medical: Amaranth Presented Interim Nine-Month Follow-up MAGNITUDE (98 micron) and Two-Year Follow-up APTITUDE (115 micron) Data at EuroPCR Symposium
Jan 02, 2018
Business Wire
Press Release: Amaranth Medical : Biodegradable Stents Market Expected to Reach $3.51 billion by 2022 - Research and Markets
Nov 02, 2017
MassDevice
Amaranth Medical: Here's how Amaranth Medical plans to get ahead with its bioresorbable scaffold tech
Oct 26, 2017
ClinicaSpace
Amaranth Medical: Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE
Jun 07, 2017
MassDevice
Amaranth Medical: Amaranth Medical looks to recapture the potential of bioresorbable scaffolds
May 16, 2017
VentureBeat
Amaranth Medical: Amaranth Medical Provides Clinical and Commercial Update on 115-micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
Jan 04, 2017
Business Wire
Press Release: Amaranth Medical : Bioabsorbable Stents Market - Material, Procedure, Absorption Rate, Drugs, Application & End User - Global Forecast to 2021 - Research and Markets
Nov 16, 2016
ePress Release
Press Release: Amaranth Medical : Report explores the bioabsorbable stents market report forecast high growth by 2022
Nov 10, 2016
Blackbird
Press Release: Amaranth Medical : Research and Markets - Global Drug Eluting Stents Market Value of USD 9.45 Billion by 2025 - Trends, Technologies & Opportunities Report 2016-2025 - Vendors: XTENT, Terumo Corp, Meril Life Sciences
Follow and Get Alerts
Amaranth Medical Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 10 + competitors
Trending Companies